Who Buys Pseudoephedrine from India — 25 Importers Behind a $11.9M Market
India's pseudoephedrine import market is served by 25 active buyers who collectively imported $11.9M across 162 shipments. OHM LABORATORIES INC (UNITED STATES) leads with a 21.5% market share, followed by VITA HEALTH PRODUCTS INC and EMBASSY PHARMACEUTICAL AND. The top 5 buyers together control 70.5% of total import value, reflecting a concentrated buyer landscape.
Pseudoephedrine buyer data — 25 importers · $11.9M market · 162 shipmentsTransData Nexus · Indian Customs Data
Top Pseudoephedrine Importers — Ranked by Import Value
OHM LABORATORIES INC (UNITED STATES) is the leading pseudoephedrine importer from India, holding a 21.5% share of the $11.9M market across 162 shipments from 25 buyers. The top 5 buyers — OHM LABORATORIES INC (UNITED STATES), VITA HEALTH PRODUCTS INC (CANADA), EMBASSY PHARMACEUTICAL AND (NIGERIA), EMBASSY PHARMACEUTICAL & CHEMICALS (NIGERIA), EMBASSY PHARMACEUTICAL AND CHEMICALS LIMITED (NIGERIA) — collectively control 70.5% of total import value.
Top Pseudoephedrine Buyers & Importers
Ranked by import value · 25 active buyers · Indian Customs (DGFT) data
Mar 2026
Top Pseudoephedrine Buyers & Importers — Ranked by Import Value. 25 active buyers with import value, shipments, country and supplier data compiled from Indian Customs records by TransData Nexus.
Which companies are buying Pseudoephedrine — and from which countries?
Flow of Pseudoephedrine exports from India: each country's share and the named importers behind the numbers
Pseudoephedrine — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Top 5 importing countries account for 97.4% of global Pseudoephedrine imports — led by Nigeria (39.0%) with a total trade value of $11.9M across 162 shipments from India.
Market Analysis: Top Importing Countries & Their Importers
1Nigeria
Nigeria emerges as the first largest importing country, achieving a total trade value of $4.6M through 41 shipments. This represents a market share of 39.0% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Nigeria has a diverse importer base, with their top importers including:
• EMBASSY PHARMACEUTICAL AND - $1.9M (40.8% of country's total business)
• EMBASSY PHARMACEUTICAL & CHEMICALS - $985.1K (21.2% of country's total business)
• EMBASSY PHARMACEUTICAL AND CHEMICALS LIMITED - $902.2K (19.4% of country's total business)
• EMBASSY PHARMACEUTICAL AND CHEMICALS LTD - $254.1K (5.5% of country's total business)
Key Insight: Nigeria demonstrates strong market positioning with an average shipment value of $113.3K, indicating premium pricing strategy compared to the market average of $73.6K.
Nigeria is a key market for Pseudoephedrine imports, representing 39.0% of total trade value.
The importation of Pseudoephedrine from India involves various buyer segments, each with distinct purchasing behaviors:
Contract Manufacturers: Entities like OHM Laboratories Inc. (United States) and Reed-Lane Inc. (United States) fall into this category. They procure Pseudoephedrine as an active pharmaceutical ingredient (API) to produce finished dosage forms for other companies. Their purchasing patterns are characterized by large, consistent orders to meet production schedules and client demands.
Distributors: Companies such as Vita Health Products Inc. (Canada) and Embassy Pharmaceutical and Chemicals Limited (Nigeria) act as intermediaries, supplying Pseudoephedrine to pharmacies, hospitals, and retailers. Their order sizes vary based on market demand, often placing frequent orders to maintain optimal inventory levels.
Re-exporters: Some buyers may function as re-exporters, importing Pseudoephedrine for distribution to neighboring countries. This segment's purchasing behavior is influenced by regional demand and trade agreements, leading to variable order sizes and frequencies.
Understanding these segments is crucial for tailoring marketing strategies and supply chain logistics to meet the specific needs of each buyer type.
Import regulations for Pseudoephedrine vary across the top importing countries:
Nigeria:
Regulatory Authority: National Agency for Food and Drug Administration and Control (NAFDAC).
Import Registration Process: Importers must obtain a Permit to Import and a Permit to Clear from NAFDAC. The process involves submitting an application with relevant documents, including a valid pharmacist's license and product details.
Estimated Timeline: Processing times can vary; however, delays may occur if documentation is incomplete or non-compliant.
Import Tariff/Duty: Specific tariff information for HS Code 30049099 is not readily available; importers should consult NAFDAC's tariff section for detailed rates. (nafdac.gov.ng)
The demand for Pseudoephedrine in importing countries is driven by several factors:
Disease Prevalence: Pseudoephedrine is commonly used to treat nasal congestion associated with colds, allergies, and sinusitis. High prevalence of these conditions in various regions contributes to consistent demand.
Government Healthcare Programs: Many countries have initiatives to improve access to essential medicines. For instance, the World Health Organization's Essential Medicines List includes Pseudoephedrine, encouraging its procurement and distribution.
Universal Health Coverage Expansion: Efforts to expand healthcare coverage increase access to medications, including Pseudoephedrine, thereby boosting demand.
Tender-Based Purchasing: Government and international health organizations often procure medicines through tenders, ensuring a steady demand for Pseudoephedrine.
With 25 buyers across 13 countries, the market for Pseudoephedrine presents opportunities for suppliers to meet the needs of diverse healthcare systems.
Common Questions — Pseudoephedrine Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest pseudoephedrine buyer importing from India?
Based on import volume and value, OHM LABORATORIES INC (UNITED STATES) leads with $2.6M in imports and a 21.5% market share — the highest of any single pseudoephedrine importer. VITA HEALTH PRODUCTS INC (CANADA) and EMBASSY PHARMACEUTICAL AND (NIGERIA) are the next largest buyers.
QHow many companies buy pseudoephedrine from India?
There are 25 active pseudoephedrine buyers importing from India, with a combined market of $11.9M across 162 shipments to 13 countries. The top 5 buyers hold 70.5% of total import value, while the remaining 20 buyers handle the other 29.5%.
QWhich countries import the most pseudoephedrine from India?
The top importing countries for pseudoephedrine from India are Nigeria (39.0%), United States (36.7%), Canada (18.5%), Kenya (2.2%), Malaysia (1.0%). These markets represent the largest demand centres for Indian pharmaceutical exports of pseudoephedrine, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for pseudoephedrine from India?
The average import transaction value for pseudoephedrine from India is , with an average unit price of . Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
The importation of Pseudoephedrine from India involves various buyer segments, each with distinct purchasing behaviors:
Contract Manufacturers: Entities like OHM Laboratories Inc. (United States) and Reed-Lane Inc. (United States) fall into this category. They procure Pseudoephedrine as an active pharmaceutical ingredient (API) to produce finished dosage forms for other companies. Their purchasing patterns are characterized by large, consistent orders to meet production schedules and client demands.
Distributors: Companies such as Vita Health Products Inc. (Canada) and Embassy Pharmaceutical and Chemicals Limited (Nigeria) act as intermediaries, supplying Pseudoephedrine to pharmacies, hospitals, and retailers. Their order sizes vary based on market demand, often placing frequent orders to maintain optimal inventory levels.
Re-exporters: Some buyers may function as re-exporters, importing Pseudoephedrine for distribution to neighboring countries. This segment's purchasing behavior is influenced by regional demand and trade agreements, leading to variable order sizes and frequencies.
Understanding these segments is crucial for tailoring marketing strategies and supply chain logistics to meet the specific needs of each buyer type.
Import regulations for Pseudoephedrine vary across the top importing countries:
Nigeria:
Regulatory Authority: National Agency for Food and Drug Administration and Control (NAFDAC).
Import Registration Process: Importers must obtain a Permit to Import and a Permit to Clear from NAFDAC. The process involves submitting an application with relevant documents, including a valid pharmacist's license and product details.
Estimated Timeline: Processing times can vary; however, delays may occur if documentation is incomplete or non-compliant.
Import Tariff/Duty: Specific tariff information for HS Code 30049099 is not readily available; importers should consult NAFDAC's tariff section for detailed rates. (nafdac.gov.ng)
The demand for Pseudoephedrine in importing countries is driven by several factors:
Disease Prevalence: Pseudoephedrine is commonly used to treat nasal congestion associated with colds, allergies, and sinusitis. High prevalence of these conditions in various regions contributes to consistent demand.
Government Healthcare Programs: Many countries have initiatives to improve access to essential medicines. For instance, the World Health Organization's Essential Medicines List includes Pseudoephedrine, encouraging its procurement and distribution.
Universal Health Coverage Expansion: Efforts to expand healthcare coverage increase access to medications, including Pseudoephedrine, thereby boosting demand.
Tender-Based Purchasing: Government and international health organizations often procure medicines through tenders, ensuring a steady demand for Pseudoephedrine.
With 25 buyers across 13 countries, the market for Pseudoephedrine presents opportunities for suppliers to meet the needs of diverse healthcare systems.
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
United States emerges as the second largest importing country, achieving a total trade value of $4.4M through 45 shipments. This represents a market share of 36.7% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United States has a diverse importer base, with their top importers including:
• OHM LABORATORIES INC - $2.6M (58.6% of country's total business)
• OHM LABORATORIES INC. - $876.8K (20.0% of country's total business)
• REED-LANE INC - $691.5K (15.8% of country's total business)
• AUROHEALTH LLC - $93.2K (2.1% of country's total business)
Key Insight: United States demonstrates strong market positioning with an average shipment value of $97.2K, indicating premium pricing strategy compared to the market average of $73.6K.
United States is a key market for Pseudoephedrine imports, representing 36.7% of total trade value.
Primary Market
Secondary Market
3Canada
Canada emerges as the third largest importing country, achieving a total trade value of $2.2M through 31 shipments. This represents a market share of 18.5% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Canada has a diverse importer base, with their top importers including:
• VITA HEALTH PRODUCTS INC - $2.1M (93.6% of country's total business)
• VITA HEALTH PRODUCTS INC. - $142.6K (6.4% of country's total business)
Key Insight: Canada demonstrates strong market positioning with an average shipment value of $71.3K, indicating competitive pricing strategy compared to the market average of $73.6K.
Canada is a key market for Pseudoephedrine imports, representing 18.5% of total trade value.
Primary Market
Secondary Market
4Kenya
Kenya emerges as the fourth largest importing country, achieving a total trade value of $260.7K through 9 shipments. This represents a market share of 2.2% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Kenya has a diverse importer base, with their top importers including:
• SUN PHARMA EAST AFRICA LIMITED - $172.9K (66.3% of country's total business)
• SAI PHARMACEUTICALS KENYA LIMITED - $71.1K (27.3% of country's total business)
Key Insight: Kenya demonstrates strong market positioning with an average shipment value of $29.0K, indicating competitive pricing strategy compared to the market average of $73.6K.
Kenya is a key market for Pseudoephedrine imports, representing 2.2% of total trade value.
Primary Market
Secondary Market
5Malaysia
Malaysia emerges as the fifth largest importing country, achieving a total trade value of $120.2K through 6 shipments. This represents a market share of 1.0% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Malaysia has a diverse importer base, with their top importers including:
• PAHANG PHARMACY SDN BHD - $92.3K (76.8% of country's total business)
Key Insight: Malaysia demonstrates strong market positioning with an average shipment value of $20.0K, indicating competitive pricing strategy compared to the market average of $73.6K.
Malaysia is a key market for Pseudoephedrine imports, representing 1.0% of total trade value.
Primary Market
Secondary Market
TransData Nexus Research · Government and regulatory sources
Mar 2026
Regulatory Authority: Food and Drug Administration (FDA) and Drug Enforcement Administration (DEA).
Import Registration Process: Importers must be registered with the DEA and obtain an import permit. Compliance with the Controlled Substances Act and the Combat Methamphetamine Epidemic Act (CMEA) is mandatory.
Estimated Timeline: Timelines can vary; importers should consult the DEA for specific processing times.
Import Tariff/Duty: Tariff rates for HS Code 30049099 are subject to change; importers should refer to the U.S. International Trade Commission for current rates.
Canada:
Regulatory Authority: Health Canada.
Import Registration Process: Importers must hold a valid establishment license and comply with the Controlled Drugs and Substances Act. A permit is required for each importation.
Estimated Timeline: Processing times can vary; importers should consult Health Canada for specific timelines.
Import Tariff/Duty: Tariff rates for HS Code 30049099 are subject to change; importers should refer to the Canada Border Services Agency for current rates.
Kenya:
Regulatory Authority: Pharmacy and Poisons Board (PPB).
Import Registration Process: Importers must register with the PPB and obtain an import permit. Compliance with the Narcotic Drugs and Psychotropic Substances Act is required.
Estimated Timeline: Processing times can vary; importers should consult the PPB for specific timelines.
Import Tariff/Duty: Tariff rates for HS Code 30049099 are subject to change; importers should refer to the Kenya Revenue Authority for current rates.
Malaysia:
Regulatory Authority: National Pharmaceutical Regulatory Agency (NPRA).
Import Registration Process: Importers must hold a valid import license and comply with the Poisons Act 1952. A permit is required for each importation.
Estimated Timeline: Processing times can vary; importers should consult the NPRA for specific timelines.
Import Tariff/Duty: Tariff rates for HS Code 30049099 are subject to change; importers should refer to the Royal Malaysian Customs Department for current rates.
Importers are advised to consult the respective regulatory authorities for the most current and detailed information.
TransData Nexus Research · Government and regulatory sourcesMar 2026
TransData Nexus Research · Government and regulatory sources
Mar 2026
$73.6K
$8.91 per unit
TransData Nexus Research · Government and regulatory sources
Mar 2026
Regulatory Authority: Food and Drug Administration (FDA) and Drug Enforcement Administration (DEA).
Import Registration Process: Importers must be registered with the DEA and obtain an import permit. Compliance with the Controlled Substances Act and the Combat Methamphetamine Epidemic Act (CMEA) is mandatory.
Estimated Timeline: Timelines can vary; importers should consult the DEA for specific processing times.
Import Tariff/Duty: Tariff rates for HS Code 30049099 are subject to change; importers should refer to the U.S. International Trade Commission for current rates.
Canada:
Regulatory Authority: Health Canada.
Import Registration Process: Importers must hold a valid establishment license and comply with the Controlled Drugs and Substances Act. A permit is required for each importation.
Estimated Timeline: Processing times can vary; importers should consult Health Canada for specific timelines.
Import Tariff/Duty: Tariff rates for HS Code 30049099 are subject to change; importers should refer to the Canada Border Services Agency for current rates.
Kenya:
Regulatory Authority: Pharmacy and Poisons Board (PPB).
Import Registration Process: Importers must register with the PPB and obtain an import permit. Compliance with the Narcotic Drugs and Psychotropic Substances Act is required.
Estimated Timeline: Processing times can vary; importers should consult the PPB for specific timelines.
Import Tariff/Duty: Tariff rates for HS Code 30049099 are subject to change; importers should refer to the Kenya Revenue Authority for current rates.
Malaysia:
Regulatory Authority: National Pharmaceutical Regulatory Agency (NPRA).
Import Registration Process: Importers must hold a valid import license and comply with the Poisons Act 1952. A permit is required for each importation.
Estimated Timeline: Processing times can vary; importers should consult the NPRA for specific timelines.
Import Tariff/Duty: Tariff rates for HS Code 30049099 are subject to change; importers should refer to the Royal Malaysian Customs Department for current rates.
Importers are advised to consult the respective regulatory authorities for the most current and detailed information.
TransData Nexus Research · Government and regulatory sourcesMar 2026
TransData Nexus Research · Government and regulatory sources
Mar 2026
Analysis Methodology
1.Buyer Identification: 25 global importers of Pseudoephedrine identified from consignee fields in DGFT shipping bill records.
2.Import Value Analysis: Total import value aggregated from 162 individual shipping bill records. Values are FOB in USD.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
4.Geographic Distribution: Buyer imports distributed across 13 destination countries with market share per buyer calculated from capped values.
